H.C. Wainwright reiterated coverage on Enlivex Therapeutics with a new price target

3/2/21 6:56:26 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

H.C. Wainwright reiterated coverage of Enlivex Therapeutics with a rating of Buy and set a new price target of $33.00 from $22.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ENLV

Date	Price Target	Rating	Analyst